Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06569329 · ClinicalTrials.gov registry record · NA
Bacterial Reduction After Supplementary Disinfection Procedures in Infected Root Canals
A NA study of Dental Pulp Necroses, sponsored by Abhishek Parolia.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06569329: Recruiting NA study of Dental Pulp Necroses, sponsored by Abhishek Parolia.
NCT06569329 is a NA study of Dental Pulp Necroses that is actively recruiting participants, run by Abhishek Parolia. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06569329, a NA study of Dental Pulp Necroses, is actively recruiting participants, sponsored by Abhishek Parolia.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the effect that 3 different types of root canal procedures have on bacteria.
Primary Outcome
Sterile paper points will be inserted into the root canal in order to collect bacteria. Real-time Polymerase Chain Reaction will be used to assess the bacterial counts.
Conditions Studied
Interventions
- DEVICE GentleWave System Root Canal Therapy
- DEVICE EdgePro Laser Root Canal Therapy
- DEVICE The ProUltra Piezo Ultrasonic with EndoUltra Tips Root Canal Therapy
Study Locations (1)
Iowa
- University of Iowa College of Dentistry and Dental Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-08-20 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06569329 shows while recruiting
NCT06569329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Dental Pulp Necroses appearing as the primary indexed condition, and to 3 interventions - of which GentleWave System Root Canal Therapy is the first listed.
NCT06569329 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT06569329 about?
NCT06569329 is a clinical study titled "Bacterial Reduction After Supplementary Disinfection Procedures in Infected Root Canals". The purpose of this study is to understand the effect that 3 different types of root canal procedures have on bacteria.
What is the current status of trial NCT06569329?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-08-20. Estimated completion is 2026-08.
What conditions does trial NCT06569329 study?
This clinical trial studies the following conditions: Dental Pulp Necroses.
What interventions are being tested in trial NCT06569329?
The interventions under investigation include: GentleWave System Root Canal Therapy (DEVICE), EdgePro Laser Root Canal Therapy (DEVICE), The ProUltra Piezo Ultrasonic with EndoUltra Tips Root Canal Therapy (DEVICE).
Who is sponsoring clinical trial NCT06569329?
This trial is sponsored by Abhishek Parolia, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06569329 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06569329's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI